Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe webpage has been updated to include new results and objectives for a study on upadacitinib, with specific details on the study's periods, safety, and efficacy data. Additionally, several locations and duplicate entries have been added or removed, reflecting changes in the study's site listings.SummaryDifference59%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
- Check43 days agoChange DetectedThe website has updated to version v2.14.2, adding 'Results Submitted' while removing 'No Results Posted' from version v2.14.1.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check65 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.